The cell culture media market was worth $5,492.90 million in 2020 and is expected to advance at a CAGR of 9.5% from 2021 to 2030 to $13,487.84 million by 2030.
Due to increased research and development investment by private and public businesses for vaccines and treatments against microorganisms, the demand for cell culture media is predicted to rise at a rapid pace.
An increase in research and development funding of cell culture media components, as well as a revolution in the life science sectors, particularly in biopharmaceutical products and the expansion and expansion of the biotechnology industry, all, contribute considerably to the sales of cell culture media.
In addition, the rising incidence and prevalence of cancer have shifted the attention to biosimilars, biologics, and recombinant protein products.
Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/REP-GB-14366
Cell culture has become an essential aspect of vaccine manufacture in the pharmaceutical business. As per the latest cell culture media market future trends, vaccine demand is predicted to rise globally as the frequency of infectious diseases rises, and the possibility of pandemics rises.
Cell-based flu vaccines have also been approved for use in the United States and many European nations.
Regulatory approval of various cell culture-based vaccines around the world and increased awareness and understanding of cell culture-based vaccines are projected to propel the adoption of cell culture media forward during the forecast period.
In order to evaluate vaccines and antivirals in vitro, a culture media must be used in which the targeted virus or bacteria is cultivated, and the response is determined.
The cell culture media market opportunities and the need for culture media are fueled by the pharmaceutical industry’s increased focus on research and development. Because biopharmaceutical innovators are at the forefront of in vitro research and development for the quest for vaccines and antivirals, the present COVID-19 outbreak has a favourable impact on the cell culture media market outlook.
The global market study on cell culture media indicates that the Asia Pacific cell culture market is expected to develop due to favourable regulatory standards, government backing for cell culture-based vaccine production, cheap manufacturing costs, and global market participants’ increasing focus on the merging Asia Pacific area.
Ethical concerns over the use of animal-derived items in culture medium and a scarcity of competent professionals are expected to limit the cell culture media market share.
Cell culture media companies entail a lot of research and development for new therapeutics, including stem cells and gene therapies. Research equipment, reagents, and other goods must be of the highest quality to get reliable results.
As a result of the increased necessity to maintain high expectations (by the use of high-grade materials) and conform to strict guidelines, the price of cell biomedical research has skyrocketed. This has led cell biology research to become out of reach for many academic institutions and small businesses with minimal resources. Thus, the cell culture market opportunities and expansion are projected to be limited.
For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14366
Key Takeaways
- Serum-free media has a large market share of 51.4 per cent in 2021. Because of the low danger of contamination, serum-free media is commonly used.
- North America has the greatest share of cell culture media applications, accounting for 32.6 per cent.
- As per the cell culture media market analysis, cancer research accounts for 43.7 per cent of the market share for cell culture media.
- Biopharmaceutical businesses have a market share of 83.3 per cent by end user, showing a growing need for stem cells and tissue engineering.
- Due to increased technological advancements in the biotechnology and pharmaceutical sectors, the creation of vaccines, and expanding initiatives for in-vitro cultivations, the Asia Pacific region is expected to have a substantial potential for growth in the cell culture media market.
Competitive Landscape
As per the cell culture media market trends and forecast, because the bulk of global culture media companies is based in North America, notably in the United States, North America has the greatest market share in the global culture media market.
HiMedia Laboratories Pvt., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Caisson Laboratories Inc., Merck & Co. Inc, Corning Incorporated, Lonza Group Ltd, Cell Culture Technologies LLC, GE Healthcare, and Fujifilm Holdings Corporation, are some of the leading cell culture media companies in the market.
As per the recent developments in cell culture media, most cultural goods were first introduced in the United States before being distributed around the world.
Due to the rising demand for cell culture mediums from various end-user industries, the top cell culture media manufacturers are focusing on increasing their research activities in plant and animal cell applications.
We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-14366
As a result, there has been an increase in competition among significant players, allowing them to improve their market position across many regions in this industry.
- Captivate Bio announced its cell culture tool portfolio in January 2021 to aid in the fight against COVID-19 and other developing diseases.
- Chemovator GmbH debuted its first product line, BIOFLOAT, a form of surface coating for cell culture consumables, in May 2020.
Explore FMI’s Extensive ongoing Coverage on Healthcare Domain
Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Market – Lymphoma is the most common type of blood cancer that affects that develops in the lymphatic system. Lymphoma are of two major types: Hodgkin lymphoma and non-Hodgkin lymphoma (NHL).
Hepatocellular Carcinoma HCC Treatment Market – Hepatocellular carcinoma (HCC) is also known as malignant hepatoma. HCC is the major malignancy of the liver and is found to occur mainly in patients with chronic liver diseases and cirrhosis.
Stem Cell Therapies Market – The stem cell therapy market is expected to grow at a CAGR of 16.7% to USD 401 million by 2026, up from USD 187 million in 2021.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/